Summary Basis of Decision for Voxzogo
Health Canada approved Voxzogo (vosoritide) with a Notice of Compliance for the treatment of achondroplasia in pediatric patients aged 2 years and older wi…
Impact analysis · 55/100 · AI-assisted priority
This score prioritizes research; it does not predict an outcome. Method and limitations.
What happened
Health Canada approved Voxzogo (vosoritide) with a Notice of Compliance for the treatment of achondroplasia in pediatric patients aged 2 years and older with open growth plates. Approval is final and based on the review of clinical data.
Quantitative evidence
- Approved indication: achondroplasia in children ≥ 2 years
- Active substance: vosoritide
- Approval: Notice of Compliance
- Patient population: pediatric with open growth plates
- Pivotal trial name/size
- Specific efficacy endpoints
- Sponsor/manufacturer
Affected entities
Analysis
The following contextual analysis is AI-assisted and separated from the reported primary-source record above.
Scientific context
Voxzogo is a C-type natriuretic peptide analogue and is the first drug therapy targeting bone growth in achondroplasia.
Market context
Voxzogo is a specialty therapy for a rare disease, likely to command a high price and impact niche markets.
Legal and regulatory context
Notice of Compliance for Voxzogo is a final regulatory approval for pediatric use in Canada.
Sources
For informational use only. Verify decisions against the linked regulator or primary source.
Evidence & limits
Source: Open the source record
- Record identifier
- 4f467e23455cae9d2ea961ab7f5dd366840f796ed7d7ef7810fc36a44f7bd9e0
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- 2026-06-05T213025Z
What it supports. The linked authority’s action, within the product, indication, jurisdiction, and procedural stage stated in that record.
Limits. A committee opinion, draft, or announcement does not by itself establish final authorization. The summary and contextual analysis are AI-assisted; a source link does not establish human review.
Connection basis. Related profiles are normalized name mentions in article text. A mention does not establish a legal relationship.